Friday, May 29, 2009

In General awards and honors

Michael Birrer, MD, PhD, director of MGH Gynecologic Medical Oncology, has been elected co-chair of the Gynecologic Cancer Steering Committee (GCSC). The GCSC determines all phase III trials for gynecologic cancers in the United States. Birrer previously served as chief of the Molecular Mechanisms Section, Cell and Cancer Biology Branch at the National Cancer Institute's (NCI) Center for Cancer Research and as the official representative from the NCI Center for Cancer Research to the GCSC.

Back to Top